Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials
In randomized clinical trials, CEE-alone increased ovarian cancer incidence and ovarian cancer mortality, while CEE plus MPA did not. By contrast, CEE plus MPA significantly reduced endometrial cancer incidence.
Authors
- Rowan T. Chlebowski (ORCID: https://orcid.org/0000-0002-4212-6184)
- Jean Wactawski‐Wende (ORCID: https://orcid.org/0000-0003-3096-9595)
- Carolyn D. Runowicz (ORCID: https://orcid.org/0000-0002-6246-3743)
- Mihae Song (ORCID: https://orcid.org/0000-0001-6457-6023)
- Aaron K. Aragaki (ORCID: https://orcid.org/0000-0001-5075-6437)
- Andrew M. Kauntiz
- Dorothy S. Lane (ORCID: https://orcid.org/0000-0003-3272-0451)
- Holly Ruth Harris (ORCID: https://orcid.org/0000-0002-2572-6727)
- Reina Haque (ORCID: https://orcid.org/0000-0001-8563-3330)
- Kathy Pan (ORCID: https://orcid.org/0000-0003-3546-2566)
- Howard D. Strickler (ORCID: https://orcid.org/0000-0002-7692-6147)
- Thomas E. Rohan
Institutions
- Albert Einstein College of Medicine (US)
- City Of Hope National Medical Center (US)
- Kaiser Permanente (US)
- Florida International University (US)
- University of Florida (US)
- Stony Brook School (US)
- Fred Hutch Cancer Center (US)
- Stony Brook University (US)
- University at Buffalo, State University of New York (US)
- Florida College (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-08-22
- DOI
- https://doi.org/10.1200/jco.23.01918
- Citations
- 16
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 9.32